1. Serum paraoxonase 1 activity and oxidant/antioxidant status in Saudi women with polycystic ovary syndrome 
Ahmed M. Mohamadin, Fawzia A. Habib, Thoraya Fadul Elahi 
Pathophysiology 
Volume 17, Issue 3, Pages (June 2010)
DOI: /j.pathophys
Copyright © 2009 Elsevier Ireland Ltd Terms and Conditions

2. Fig. 1
Serum paraoxonase 1 (PON1) activity in women with polycystic ovary syndrome (PCOS) and healthy controls. *Significantly different from healthy control (p<0.01).
Pathophysiology  , DOI: ( /j.pathophys )
Copyright © 2009 Elsevier Ireland Ltd Terms and Conditions

3. Fig. 2
Serum malondialdehyde (MDA) levels in women with polycystic ovary syndrome (PCOS) and healthy controls. *Significantly different from healthy control (p<0.01).
Pathophysiology  , DOI: ( /j.pathophys )
Copyright © 2009 Elsevier Ireland Ltd Terms and Conditions

4. Fig. 3
Serum total antioxidant status (TAS) in women with polycystic ovary syndrome (PCOS) and healthy controls. *Significantly different from healthy control (p<0.01).
Pathophysiology  , DOI: ( /j.pathophys )
Copyright © 2009 Elsevier Ireland Ltd Terms and Conditions

5. Fig. 4
Correlation coefficient between HOMA-IR (A), testosterone (B), FAI (C), MDA (D), TAS (E), HDL-C (F) and serum PON1 activity Serum in women with polycystic ovary syndrome.
Pathophysiology  , DOI: ( /j.pathophys )
Copyright © 2009 Elsevier Ireland Ltd Terms and Conditions